Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
MMWR. Morbidity and Mortality Weekly Report|November 30, 2023
SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023Ayzsa Tannis, Janet A Englund, Ariana Perez, et al.
Pediatrics|January 7, 2026
Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2 Years Hospitalized With RSVAbigail L Salthouse, Ayzsa Tannis, Rachel E Rutkowski, et al.
The Journal of Pediatrics|April 1, 2024
Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5 Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019Benjamin R Clopper, Yingtao Zhou, Ayzsa Tannis, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2024
Birth Outcomes Related to Prenatal Zika, Dengue, and Other Flavivirus Infections in the Zika en Embarazadas y Niños Prospective Cohort Study in ColombiaAyzsa Tannis, Suzanne Newton, Angelica Rico, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
JAMA Pediatrics|December 9, 2024
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
MMWR. Morbidity and Mortality Weekly Report|March 12, 2026
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026Patrick Maloney, Emily L Reeves, Kristina Wielgosz, et al.
MMWR. Morbidity and Mortality Weekly Report|May 8, 2025
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025Monica E Patton, Heidi L Moline, Michael Whitaker, et al.
Pageof 2